GB9516943D0 - Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs - Google Patents

Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs

Info

Publication number
GB9516943D0
GB9516943D0 GBGB9516943.9A GB9516943A GB9516943D0 GB 9516943 D0 GB9516943 D0 GB 9516943D0 GB 9516943 A GB9516943 A GB 9516943A GB 9516943 D0 GB9516943 D0 GB 9516943D0
Authority
GB
United Kingdom
Prior art keywords
secoprecursors
cyclopropylindoles
prodrugs
novel
novel cyclopropylindoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9516943.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Society of New Zealand Auckland Dvision
Original Assignee
Cancer Society of New Zealand Auckland Dvision
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Society of New Zealand Auckland Dvision filed Critical Cancer Society of New Zealand Auckland Dvision
Priority to GBGB9516943.9A priority Critical patent/GB9516943D0/en
Publication of GB9516943D0 publication Critical patent/GB9516943D0/en
Priority to NZ315410A priority patent/NZ315410A/xx
Priority to EP96927217A priority patent/EP0850220A1/en
Priority to CA002229264A priority patent/CA2229264A1/en
Priority to PCT/NZ1996/000083 priority patent/WO1997007097A1/en
Priority to JP8531337A priority patent/JPH11511113A/ja
Priority to US09/011,883 priority patent/US5985909A/en
Priority to AU67109/96A priority patent/AU707644B2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
GBGB9516943.9A 1995-08-18 1995-08-18 Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs Pending GB9516943D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9516943.9A GB9516943D0 (en) 1995-08-18 1995-08-18 Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
NZ315410A NZ315410A (en) 1995-08-18 1996-08-19 Substituted seco indolines and their use as prodrugs for adept and gdept
EP96927217A EP0850220A1 (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs
CA002229264A CA2229264A1 (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs
PCT/NZ1996/000083 WO1997007097A1 (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs
JP8531337A JPH11511113A (ja) 1995-08-18 1996-08-19 シクロプロピルインドール類およびそのセコ前駆体、ならびにプロドラッグとしてのこれらの使用
US09/011,883 US5985909A (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs
AU67109/96A AU707644B2 (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516943.9A GB9516943D0 (en) 1995-08-18 1995-08-18 Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs

Publications (1)

Publication Number Publication Date
GB9516943D0 true GB9516943D0 (en) 1995-10-18

Family

ID=10779431

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9516943.9A Pending GB9516943D0 (en) 1995-08-18 1995-08-18 Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs

Country Status (8)

Country Link
US (1) US5985909A (https=)
EP (1) EP0850220A1 (https=)
JP (1) JPH11511113A (https=)
AU (1) AU707644B2 (https=)
CA (1) CA2229264A1 (https=)
GB (1) GB9516943D0 (https=)
NZ (1) NZ315410A (https=)
WO (1) WO1997007097A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334344A (en) * 1996-09-12 2000-08-25 Cancer Res Campaign Tech benzo[e]indole and pyrrolo[3,2-e]indole compounds and their use as prodrugs
US6130237A (en) * 1996-09-12 2000-10-10 Cancer Research Campaign Technology Limited Condensed N-aclyindoles as antitumor agents
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
EP0887348A1 (en) * 1997-06-25 1998-12-30 Boehringer Mannheim Italia S.p.A. Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
DE69930328T2 (de) 1998-08-27 2006-12-14 Spirogen Ltd., Ryde Dimere Pyrrolobenzodiazepine
US6909006B1 (en) * 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
EP2357009A1 (en) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
ZA200507752B (en) * 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
CN102746336B (zh) 2005-06-29 2015-08-19 施瑞修德制药公司 氨基磷酸酯烷化剂前体药物
EP1994000B1 (en) * 2006-02-02 2017-08-23 Syntarga B.V. Water-soluble cc-1065 analogs and their conjugates
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2114157B1 (en) * 2006-12-26 2021-05-26 ImmunoGenesis, Inc. Phosphoramidate alkylator prodrug for the treatment of cancer
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US20090118031A1 (en) * 2007-11-01 2009-05-07 Qualizza Gregory K Shaft Structure with Configurable Bending Profile
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
AU2011243294C1 (en) 2010-04-21 2015-12-03 Syntarga B.V. Novel conjugates of CC-1065 analogs and bifunctional linkers
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
EP2970269B1 (en) 2013-03-14 2017-04-19 Novartis AG 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
EP3089963A1 (en) 2013-10-30 2016-11-09 Novartis AG 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
AU2022238571A1 (en) 2021-03-18 2023-09-14 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340243B1 (en) * 1986-12-19 1994-09-28 The Upjohn Company Cc-1065 analogs
GB8705477D0 (en) * 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
AU648313B2 (en) * 1990-04-25 1994-04-21 Pharmacia & Upjohn Company Novel CC-1065 analogs
CA2122036C (en) * 1991-10-23 2002-09-17 Gillian Anlezark Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
NZ240785A (en) * 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments
GB9314960D0 (en) * 1992-07-23 1993-09-01 Zeneca Ltd Chemical compounds
GB9323008D0 (en) * 1993-11-05 1994-01-05 Connors Thomas Improvements relating to cancer therapy

Also Published As

Publication number Publication date
US5985909A (en) 1999-11-16
AU6710996A (en) 1997-03-12
WO1997007097A1 (en) 1997-02-27
EP0850220A1 (en) 1998-07-01
AU707644B2 (en) 1999-07-15
NZ315410A (en) 1999-07-29
CA2229264A1 (en) 1997-02-27
JPH11511113A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
GB9516943D0 (en) Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
ZA968451B (en) Novel sulfonylaminopyrimidines
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
GB9508637D0 (en) New use
AP9600802A0 (en) Libricant
GB9516952D0 (en) Further cyclopropylindoles and their secoprecursors,and their use as prodrugs
ZA963484B (en) New use
GB9616624D0 (en) Headgear
ZA968953B (en) 24-homo-26,27-hexafluoro-cholecalciferols
GB9526273D0 (en) New prodrugs
GB9503206D0 (en) Novel use
GB2306135B (en) Stationery sets
CA76640S (en) Hat
GB9520121D0 (en) Use
GB9520119D0 (en) Use
GB9519915D0 (en) Use
GB9519905D0 (en) Use
GB9505071D0 (en) Use
AU1105P (en) DALESE Metrosideros excelsus
GB9516136D0 (en) New Use
ZA961105B (en) Substituted heterocycloalkenes
ZA9610253B (en) Novel compounds and their use as medicaments.
SI0874814T1 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
GB9508049D0 (en) Snapper
PL103582U1 (en) Overall